Menu
Back to Journals » International Journal of Nanomedicine » Volume 11
Original Research
A combination of sorafenib and nilotinib reduces the growth of castrate-resistant prostate cancer
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 16,493 | Dovepress* | 15,014+ | 1,605 | 16,619 | |
| PubMed Central* | 1,479 | 374 | 1,853 | ||
| Totals | 16,493 | 1,979 | 18,472 | ||
|
*Since 8 January 2016 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 6 | 0 | 0 | 0 | 3 | 3 |
View citations on PubMed Central and Google Scholar